Medicure Inc.
MPH.VTSXVHealthcare● Active
$1.04
$-0.04(-3.70%)
Market Cap$10853766
P/E Ratio—
52W High$1.43
52W Low$0.85
Medicure Inc. (MPH.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MPH.V · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 21, 2026EPS Actual
-$0.04
Est. -$0.06 · +35.2%
Revenue
$0.01B
Est. $0.00B · +60.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 21, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
MPH.V reports quarterly as a TSXV-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 26, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 19, 2026 | -$0.09 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 21, 2026 | -$0.06 | -$0.04 | +35.2% | $0.01B | $0.00B | +60.4% |
| ◌ Q2 FY2026 | May 21, 2026 | — | — | — | — | — | — |
| ▼ Q2 FY2026 | Apr 23, 2026 | -$0.13 | -$0.40 | -207.7% | $0.01B | $0.00B | +109.0% |
| ◌ Q2 FY2026 | Apr 23, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | Apr 22, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Nov 19, 2025 | — | -$0.13 | — | $0.01B | — | — |
Q3 FY2026
Aug 26, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 19, 2026
EPS Actual
—
EPS Est.
-$0.09
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 21, 2026Beat
EPS Actual
-$0.04
EPS Est.
-$0.06
EPS Surpr.
+35.2%
Revenue
$0.01B
Q2 FY2026
May 21, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 23, 2026Miss
EPS Actual
-$0.40
EPS Est.
-$0.13
EPS Surpr.
-207.7%
Revenue
$0.01B
Q2 FY2026
Apr 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 22, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 19, 2025
EPS Actual
-$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q1 FY2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q4 FY2025 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q3 FY2025 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q2 FY2025 | $-0.13 | $-0.13 | $-0.13 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 21, 2026 | +35.2% | $1.20 | $1.10 | -8.33% |
| ▼ Q2 FY2026 | Apr 23, 2026 | -207.7% | $1.35 | $1.35 | +0.00% |
| — Q4 FY2025 | Nov 19, 2025 | — | $1.06 | $1.43 | +34.91% |
| — Q3 FY2025 | Aug 20, 2025 | — | $1.05 | $1.05 | +0.00% |
| — Q2 FY2025 | Apr 28, 2025 | — | $0.83 | $0.83 | +0.00% |
| — Q4 FY2024 | Nov 19, 2024 | — | $0.88 | $0.88 | +0.00% |
| — Q3 FY2024 | Aug 14, 2024 | — | $1.05 | $1.00 | -4.76% |
Q2 FY2026-8.33%
Report Date
May 21, 2026
EPS Beat/Miss
+35.2%
Price Before
$1.20
Price After
$1.10
Q2 FY2026+0.00%
Report Date
Apr 23, 2026
EPS Beat/Miss
-207.7%
Price Before
$1.35
Price After
$1.35
Q4 FY2025+34.91%
Report Date
Nov 19, 2025
EPS Beat/Miss
—
Price Before
$1.06
Price After
$1.43
Q3 FY2025+0.00%
Report Date
Aug 20, 2025
EPS Beat/Miss
—
Price Before
$1.05
Price After
$1.05
Q2 FY2025+0.00%
Report Date
Apr 28, 2025
EPS Beat/Miss
—
Price Before
$0.83
Price After
$0.83
Q4 FY2024+0.00%
Report Date
Nov 19, 2024
EPS Beat/Miss
—
Price Before
$0.88
Price After
$0.88
Q3 FY2024-4.76%
Report Date
Aug 14, 2024
EPS Beat/Miss
—
Price Before
$1.05
Price After
$1.00
Avg Beat Reaction-8.33%
Avg Miss Reaction+0.00%
Beat Rate1 / 7 quarters
Largest Move+34.91% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MPH.V ends December
Medicure Inc. (MPH.V) most recently reported earnings on May 21, 2026 for Q2 FY2026, posting EPS of $-0.04 — beating the analyst consensus of $-0.06 by +35.2%. The next MPH.V earnings date is expected around September 1, 2026.
Each quarter, investors track MPH.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MPH.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MPH.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MPH.V earnings · 5 questionsMedicure Inc.'s next earnings report is expected around September 1, 2026. MPH.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MPH.V historically reports after market close (AMC).
MPH.V earnings datewhen is MPH.V earningsMPH.V next earnings datewhen does MPH.V report earningsMPH.V earnings calendar
▸ Source: FMP · Medicure Inc. SEC filings · US GAAP · Medicure Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026